Skip to content

Feasibility of high-intensity interval training with hyperoxia in cancer patients undergoing chemotherapy

Feasibility of high-intensity interval training with hyperoxia in cancer patients undergoing chemotherapy - Hyperoxie Studie

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00011689
Enrollment
48
Registered
2017-02-27
Start date
2017-07-25
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

all carcinoma (except for lung carcinoma) C00-C97

Interventions

Group 1: 2 times weekly high intensity interval training in normoxic conditions (no modified oxygen concentrations) for 4 weeks Group 2: 2 times weekly high intensity interval training in hyperoxic c

Sponsors

Deutsche Sporthochschule Köln, Institut für Kreislaufforschung und Sportmedizin, Abt.2: Molekulare und Zelluläre Sportmedizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Men with carcinoma undergoing chemotherapy as an adjuvant or primary therapy Patients treated with conventional chemotherapy: - Alkylating agents - Antimetabolites - Anthracyclines - Taxanes - Vincaalcaloides - Patients treated with antibody therapy

Exclusion criteria

Exclusion criteria: - Patients with lung-ca - Relapsed carcinoma - Recent serious cardiovascular events (including but not limited to poorly controlled hypertension and congestive heart failure) - Medical condition such as uncontrolled infection or cardiac disease that, in the opinion of the physician, would make this protocol unreasonably hazardous for the patient - Psychiatric illness, which would prevent the patient from giving informed consent or adhering to the study protocol - Known spinal cord compromise or instrumentation due to metastatic disease. Radiation therapy for metastatic disease is allowed - Peripheral neuropathy - Men participating in vigorous aerobic exercise for more than 60 minutes per week or resistance exercise two or more days per week - shortness of breath, chest discomfort, or palpitations when performing activities of daily living - Men having difficulties of climbing a flight of stairs due to physical impairment - Ongoing restriction of physical activity with physician documentation - chest pain brought on by physical activity and chest pain developed in the past month - Patients with carcinoma which limit physical exercise on a bike ergometer

Design outcomes

Primary

MeasureTime frame
Feasibility and compliance assessed by the following questionnaires (at baseline and after 4 weeks of training): BPI-SF (Brief Pain Inventory - Short Form) FACIT-F (Functional Assessment of Chronic Illness Therapy - Fatigue) FACIT-TS-G (Functional Assessment of Chronic Illness Therapy - Treatment rating) PSQI (Pittsburgh Sleep Quality Index) Immune status assessed by venous blood analyses (at baseline and after 4 weeks of training).

Secondary

MeasureTime frame
Cognitive function assessed by questionnaire FACT-Cog (Functional Assessment of Cancer Therapy - Cognitive Function) (Baseline and after 4 weeks of training) Quality of life assessed by questionnaire EORTC-QLQ-C30 (European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire) (Baseline und nach 4 Wochen Training) Health perception assessed by questionnaire EQ-5D (EuroQol five dimensions questionnaire) (Baseline and after 4 weeks of training) Aerobic capacity assessed by incremental cycle ergometer test (Baseline and after 4 weeks of training) Maximal strength of leg exensors assessed by a dynamic one repetition maximum test (Baseline and after 4 weeks of training) Physiological and psychological stress assessed by heart rate variability (3 x wöchentlich) Arterial stiffnes assessed by pulse wave analysis (Baseline and after 4 weeks of training) Additional biochemical analyses by venous blood samples (Baseline and after 4 weeks of training) Acute loading measurements: In addition, acute responses to a single training session will also be assessed throughout and after the first (week 1) and last (week 4) training session. These include: Assessment of Blood lactate concentrations Assessment of Fatigue (FACIT-F) Assessment of Rate of perceived Exertion (RPE Scale) Assessment of heart rate Assessment of heart rate variability Oxygen saturation

Countries

Germany

Contacts

Public ContactMoritz Schumann

Deutsche Sporthochschule Köln, Institut für Kreislaufforschung und Sportmedizin, Abt. 2: Molekulare und Zelluläre Sportmedizin

m.schumann@dshs-koeln.de0221 4982 4821

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026